文献速递药物不良反应与药物警戒

呼吁将系统理论与人为因素纳入临床研究危害调查

A call to incorporate systems theory and human factors into the existing investigation of harm in clinical research involving healthcare products.
PubMed 文献 · Br J Clin Pharmacol · 2017-07-19

本文是药理学与药学专业人士(包括ACRES和ISoP成员)的联合声明,呼吁在已有药理学和监管调查基础上,对临床研究中严重伤害事件(从首次人体试验开始)采用更全面的系统方法。建议融合药理学与组织科学证据,关注人为因素与透明度,以促进组织学习和持续改进。

要点

  • 临床研究严重伤害调查需补充系统理论与人为因素方法。
  • 应融合药理学与组织科学证据,提升调查客观性和透明度。
  • 重复发生的可预防不良结局需紧急改变,以识别系统脆弱性。

核心结论

  • 临床研究中的危害调查应纳入系统理论和人为因素,以补充现有药理学与监管调查。

研究设计与样本

  • 药理学与药学专业人士以个人身份发表的联合声明,包括ACRES和ISoP成员。

主要发现

  • 基于系统理论和人为因素的方法更可能提高客观性和透明度,改善系统设计。

临床怎么用

  • 在临床研究严重伤害事件调查中,除药理学证据外,应整合组织科学证据并关注人为因素与透明度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This is a joint statement from individual pharmacology and pharmaceutical professionals acting in their own capacity, including members of the Alliance for Clinical Research Excellence and Safety (ACRES) and the International Society of Pharmacovigilance (ISoP). By building on the extensive pharmacological and regulatory investigations that already take place, we are calling for a fuller and more robust systems-based approach to the independent investigation of clinical research when serious incidents of harm occur, starting with first-in-human clinical trials. To complement existing activities and regulations, we propose an additional approach blending evidence derived from both pharmacological and organizational science, which addresses human factors and transparency, to enhance organizational learning and continuous improvement. As happens with investigations in other sectors of society, such as the chemical and aviation sector, this systems approach should be seen as an additional way to understand how problems occur and how they might be prevented in the future. We believe that repetition of potentially preventable and adverse outcomes during clinical research, by failing to identify and act upon all systematic vulnerabilities, is a situation that needs urgent change. As we will discuss further on, approaches based on applying systems theory and human factors are much more likely to improve objectivity and transparency, leading to better system design.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Edwards BD, Bégaud B, Daemen E, et al. A call to incorporate systems theory and human factors into the existing investigation of harm in clinical research involving healthcare products. Br J Clin Pharmacol. 2017. PMID: 28681444. doi:10.1111/bcp.13353

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。